Removal of naproxen, salicylic acid, clofibric acid, and carbamazepine by water phase adsorption onto inorganic-organic-intercalated bentonites modified with transition metal cations

Environmental Engineering Science

Volumn 28, Issue 3, 2011, Pages 171-182

  Rivera Jimenez, Sindia M ^a   Lehner, Michael M ^a   Cabrera Lafaurie, Wilman A ^a   Hernández Maldonado, Arturo J ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

adsorption; clays; PPCPs; transition metals; water treatment

Indexed keywords

ADSORBATE CONCENTRATION; ADSORPTION CAPACITIES; ADSORPTION EXPERIMENT; CARBAMAZEPINE; CLOFIBRIC ACID; COMPLEXATION INTERACTIONS; EMERGING CONTAMINANT; INORGANIC-ORGANIC; LOW CONCENTRATIONS; METAL LOADINGS; NAPROXENS; PH CONDITION; POROSIMETRY; PPCPS; ROOM TEMPERATURE; SALICYLIC ACIDS; THERMAL GRAVIMETRIC ANALYSIS; TRANSITION METAL CATIONS; WATER PHASE;

ADSORBATES; ADSORPTION; AMIDES; BENTONITE; CHEMICALS REMOVAL (WATER TREATMENT); COMPLEXATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FUNCTIONAL GROUPS; LOADING; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRIC ANALYSIS; TRANSITION METALS; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

DEWATERING;

BENTONITE; CARBAMAZEPINE; CLOFIBRATE; COBALT; COPPER; INORGANIC COMPOUND; NAPROXEN; NICKEL; ORGANIC COMPOUND; SALICYLIC ACID; TRANSITION ELEMENT; WATER;

ADSORPTION; ARTICLE; CLAY; COMPLEX FORMATION; FOURIER TRANSFORMATION; INFRARED SPECTROSCOPY; PH; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; THERMOGRAVIMETRY; WASTE WATER MANAGEMENT; WATER CONTENT; X RAY DIFFRACTION;

EID: 79952304232     PISSN: 10928758     EISSN: None     Source Type: Journal    
DOI: 10.1089/ees.2010.0213     Document Type: Article

References (64)

1. Aga, D.S. (2008). Fate of Pharmaceuticals in the Environment and in Water Treatment Systems. Boca Raton: CRC Press.
2. Ayranci, E., and Duman, O. (2006). Adsorption of aromatic organic acids onto high area activated carbon cloth in relation to wastewater purification. J. Hazard. Mater. 136, 542.
3. Baes, C.F., and Mesmer, R.E. (1986). The Hydrolysis of Cations. Malabar, FL: R.E. Krieger.
4. Bendz, D., Paxeus, N.A., Ginn, T.R., and Loge, F.J. (2005). Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 122, 195.
5. Benotti, M.J., Trenholm, R.A., vanderford, B.J., Holady, J.C., Stanford, B.D., and Snyder, S.A. (2009). Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 43, 597.
6. Caliman, F.A., and Gavrilescu, M. (2009). Pharmaceuticals, personal care products and endocrine disrupting agents in the environment: a review. Clean Soil Air Water 37, 277.
7. Carballa, M., Omil, F., and Lema, J.M. (2005). Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res. 39, 4790.
8. Celiz, M.D., Tso, J., and Aga, D.S. (2009). Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ. Toxicol. Chem. 28, 2473.
9. Chang, P.H., Li, Z.H., Yu, T.L., Munkhbayer, S., Kuo, T.H., Hung, Y.C., Jean, J.S., and Lin, K.H. (2009). Sorptive removal of tetracycline from water by palygorskite. J. Hazard. Mater. 165, 148.
10. Christensen, F.M. (1998). Pharmaceuticals in the environment: a human risk? Regul. Toxicol. Pharm. 28, 212.
11. Cini, R., Tamasi, G., Defazio, S., and Hursthouse, M.B. (2007). Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper( II): synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex. J. Inorg. Biochem. 101, 1140.
12. Cleuvers, M. (2004). Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotox. Environ. Safe. 59, 309.
13. Cunningham, v.L., Binks, S.P., and Olson, M.J. (2009). Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul. Toxicol. Pharm. 53, 39.
14. Daughton, C.G., and Ternes, T.A. (1999). Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 107, 907.
15. Drillia, P., Stamatelatou, K., and Lyberatos, G. (2005). Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 60, 1034.
16. Esplugas, S., Bila, D.M., Krause, L.G.T., and Dezotti, M. (2007). Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J. Hazard. Mater. 149, 631.
17. Farmer, v.C. (1974). The Infrared Spectra of Minerals. London: Mineralogical Society.
18. Frimmel, F.H., Assenmacher, M., Kumke, M.U., Specht, C., Abbt-Braun, G., and Grä be, G. (2002). Removal of hydrophilic compounds from water with organic polymers: Part II: adsorption behavior of industrial wastewater. Chem. Eng. Process. 41, 731.
19. Gros, M., Petrovic, M., Ginebreda, A., and Barcelo, D. (2010). Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 36, 15.
20. Guan, X.H., Shang, C., and Chen, G.H. (2006). ATR-FTIR investigation of the role of phenolic groups in the interaction of some NOM model compounds with aluminum hydroxide. Chemosphere 65, 2074.
21. Halford, B. (2008). Side effects. Chem. Eng. News 86, 13.
22. Hari, A.C., Paruchuri, R.A., Sabatini, D.A., and Kibbey, T.C.G. (2005). Effects of pH and cationic and nonionic surfactants on the adsorption of pharmaceuticals to a natural aquifer material. Environ. Sci. Technol. 39, 2592.
23. He, H.P., Yang, D., Yuan, P., Shen, W., and Frost, R.L. (2006a). A novel organoclay with antibacterial activity prepared from montmorillonite and chlorhexidini acetas. J. Colloid Interface Sci. 297, 235.
24. He, H.P., Zhou, Q., Martens, W.N., Kloprogge, T.J., Yuan, P., Yunfei, X.F., Zhui, J.X., and Frost, R.L. (2006b). Microstructure of HDTMAp-modified montmorillonite and its influence on sorption characteristics. Clays Clay Miner. 54, 689.
25. Hedley, C.B., Yuan, G., and Theng, B.K.G. (2007). Thermal analysis of montmorillonites modified with quaternary phosphonium and ammonium surfactants. Appl. Clay Sci. 35, 180.
26. Huber, M.M., Korhonen, S., Ternes, T.A., and von Gunten, U. (2005). Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res. 39, 3607.
27. Jones, O.A.H., voulvoulis, N., and Lester, J.N. (2005). Human pharmaceuticals in wastewater treatment processes. Crit. Rev. Environ. Sci. Tech. 35, 401.
28. Khetan, S.K., and Collins, T.J. (2007). Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem. Rev. 107, 2319.
29. Klavarioti, M., Mantzavinos, D., and Kassinos, D. (2009). Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ. Int. 35, 402.
30. Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., and Buxton, H.T. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36, 1202.
31. Kovala-Demertzi, D. (2006). Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: organotin complexes of NSAIDs. J. Organomet. Chem. 691, 1767.
32. Kovala-Demertzi, D., Skrzypek, D., Szymanska, B., Galani, A., and Demertzis, M.A. (2005). EPR spectroscopic study of a dinuclear copper(II) complex of tolfenamic acid. Inorg. Chim. Acta 358, 186.
33. Kowalska, M., Gü ler, H., and Cocke, D.L. (1994). Interactions of clay minerals with organic pollutants. Sci. Total Environ. 141, 223.
34. Kummerer, K. (2009). The presence of pharmaceuticals in the environment due to human use: present knowledge and future challenges. J. Environ. Manage. 90, 2354.
35. Kummerer, K., and Al-Ahmad, A. (2010). Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environ. Sci. Pollut. Res. 17, 486.
36. Lee, Y.J., Lee, S.E., Lee, D.S., and Kim, Y.H. (2008). Risk assessment of human antibiotics in Korean aquatic environment. Environ. Toxicol. Pharmacol. 26, 216.
37. Lorphensri, O., Intravijit, J., Sabatini, D.A., Kibbey, T., Osathaphan, K., and Saiwan, C. (2006). Sorption of acetaminophen, 17 alpha-ethynyl stradiol, nalidixic acid, and norfloxacin to silica, alumina, and a hydrophibic medium. Water Res. 40, 1481.
38. Lowell, S. (2006). Characterization of Porous Solids and Powders: Surface area, Pore Size, and Density. Dordrecht; Boston: Springer.
39. Marsal, A., Bautista, E., Ribosa, I., Pons, R., and Garcia, M.T. (2009). Adsorption of polyphenols in wastewater by organobentonites. Appl. Clay Sci. 44, 151.
40. Martin-Diaz, L., Franzellitti, S., Buratti, S., valbonesi, P., Capuzzo, A., and Fabbri, E. (2009). Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 94, 177.
41. Matito, E., and Sola, M. (2009). The role of electronic delocalization in transition metal complexes from the electron localization function and the quantum theory of atoms in molecules viewpoints. Coord. Chem. Rev. 253, 647.
42. Mompelat, S., Le Bot, B., and Thomas, O. (2009). Occurrence and fate of pharmaceutical products and by-products: from resource to drinking water. Environ. Int. 35, 803.
43. Ramirez, A.J., Brain, R.A., Usenko, S., Mottaleb, M.A., O'Donnell, J.G., Stahl, L.L., Wathen, J.B., Snyder, B.D., Pitt, J.L., Perez- Hurtado, P, et al. (2009). Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ. Toxicol. Chem. 28, 2587.
44. Rivera-Jimenez, S.M., and Hernandez-Maldonado, A.J. (2008). Nickel(II) grafted MCM-41: a novel sorbent for the removal of Naproxen from water. Micropor. Mesopor. Mat. 116, 246.
45. 2+) grafted mesoporous SBA-15: effect of transition metal incorporation and pH conditions on the adsorption of Naproxen from water. Micropor. Mesopor. Mat. 132, 470.
46. Robberson, K.A., Waghe, A.B., Sabatini, D.A., and Butler, E.C. (2006). Adsorption of the quinolone antibiotic nalidixic acid onto anion-exchange and neutral polymers. Chemosphere 63, 934.
47. Rohricht, M., Krisam, J., Weise, U., Kraus, U.R., and During, R.A. (2009). Elimination of carbamazepine, diclofenac and naproxen from treated wastewater by nanofiltration. Clean Soil Air Water 37, 638.
48. Rosal, R., Rodriguez, A., Gonzalo, M.S., and Garcia-Calvo, E. (2008). Catalytic ozonation of naproxen and carbamazepine on titanium dioxide. Appl. Catal. B. Environ. 84, 48.
49. San Miguel, G., Lambert, S.D., and Graham, N.J.D. (2006). A practical review of the performance of organic and inorganic adsorbents for the treatment of contaminated waters. J. Chem. Technol. Biotechnol. 81, 1685.
50. Sanchez-Polo, M., Lopez-Penalver, J., Prados-Joya, G., Ferro- Garcia, M.A., and Rivera-Utrilla, J. (2009). Gamma irradiation of pharmaceutical compounds, nitroimidazoles, as a new alternative for water treatment. Water Res. 43, 4028.
51. Santos, J.L., Aparicio, I., Callejon, M., and Alonso, E. (2009). Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J. Hazard. Mater. 164, 1509.
52. Snyder, S.A., Westerhoff, P., Yoon, Y., and Sedlak, D.L. (2003). Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 20, 449.
53. Ternes, T.A., Joss, A., and Siegrist, H. (2004). Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol. 38, 392A.
54. Ternes, T.A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H.J., Gulde, B.H., Preuss, G., Wilme, U., and Seibert, N.Z. (2002). Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36, 3855.
55. Wang, C.C., Juang, L.C., Lee, C.K., Hsu, T.C., Lee, J.F., and Chao, H.P. (2004). Effects of exchanged surfactant cations on the pore structure and adsorption characteristics of montmorillonite. J. Colloid Interface Sci. 280, 27.
56. Weder, J.E., Dillon, C.T., Hambley, T.W., Kennedy, B.J., Lay, P.A., Biffin, J.R., Regtop, H.L., and Davies, N.M. (2002). Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Coord. Chem. Rev. 232, 95.
57. Wu, P.X., Liao, Z.W., Zhang, H.F., and Guo, J.C. (2001). Adsorption of phenol on inorganic-organic pillared montmorillonite in polluted water. Environ. Int. 26, 401.
58. Xu, J., Wu, L.S., and Chang, A.C. (2009). Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils. Chemosphere 77, 1299.
59. Yaqub, S., Ihsan Ul, H., Ali, S., Mirza, B., Ahmed, F., and Shahzadi, S. (2009). Interaction of Naproxen with transition metals: synthesis, characterization, anti-inflammatory activity and kinetic studies. J. Coord. Chem. 62, 3463.
60. Yu, Z.R., Peldszus, S., and Huck, P.M. (2008). Adsorption characteristics of selected pharmaceuticals and an endocrine disrupting compound: naproxen, carbamazepine and nonylphenol - on activated carbon. Water Res. 42, 2873.
61. Zhou, Q., He, H.P., Zhu, J.X., Shen, W., Frost, R.L., and Yuan, P. (2008). Mechanism of p-nitrophenol adsorption from aqueous solution by HDTMAp-pillared montmorillonite: implications for water purification. J. Hazard. Mater. 154, 1025.
62. Zhu, L.Z., and Chen, B.L. (2009). Use of bentonite-based sorbents in organic pollutant abatements. Prog. Chem. 21, 420.
63. Zhu, R.L., Wang, T., Ge, F., Chen, W.X., and You, Z.M. (2009a). Intercalation of both CTMAB and Al13 into montmorillonite. J. Colloid Interface Sci. 335, 77.
64. Zhu, R.L., Zhu, L.Z., Zhu, J.X., Ge, F., and Wang, T. (2009b). Sorption of naphthalene and phosphate to the CTMAB-Al13 intercalated bentonites. J. Hazard. Mater. 168, 1590.